CLIMB 2026: Contemporary Landscapes in Muscle Biology

Cytokinetics • South San Francisco, CA

1d

About The Position

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. You’re invited to CLIMB 2026, a muscle-biology-focused research symposium. CLIMB will feature distinguished speakers alongside a lineup of poster presentations from both seasoned experts and budding researchers in muscle biology. We would be honored to have you join us to forge valuable connections with fellow attendees. Additionally, we invite you to present a poster at the conference to showcase your research. To register to attend or to submit an abstract for consideration, visit the Climbsymposium.com. TIME May 29, 2026 8:00am-5:00pm PLACE Mission Bay Conference Center 1675 Owens St San Francisco, CA 94158 Expert speakers include: James Spudich, Ph.D. Co-Founder, Cytokinetics Stanford University School of Medicine Department of Biochemistry Siddique Abbasi, M.D., MSc Amgen Michael Alexanian, Ph.D. Gladstone Institute, University of California, San Francisco Erik Ingelsson, M.D., Ph.D. Wave Life Sciences Laura Lombardi, Ph.D. Tenaya Therapeutics Elizabeth McNally, M.D., Ph.D. Northwestern University Feinberg School of Medicine Javid Moslehi, M.D. University of California, San Francisco April Pyle, Ph.D. University of California, Los Angeles Rong Tian, M.D., Ph.D. University of Washington Amy Wagers, Ph.D. Harvard University and Joslin Diabetes Center Keynote Speaker ABOUT THE EVENT CLIMB (Contemporary Landscapes in Muscle Biology) is a one-day event bringing together scientists, researchers and emerging professionals to share innovative research in the field of muscle biology. The symposium seeks to foster collaboration, facilitate networking opportunities and promote interdisciplinary dialogue, with the ultimate goal of driving advancements in the understanding and treatment of muscle-related diseases and disorders. CLIMB is being sponsored by Cytokinetics. To register to attend or to submit an abstract for consideration, visit the Climbsymposium.com. Pay Range: Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you. Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying. Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves. Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process. Here are some ways to check for authenticity: We do not conduct job interviews through non-standard text messaging applications We will never request personal information such as banking details until after an official offer has been accepted and verified We will never request that you purchase equipment or other items when interviewing or hiring If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at [email protected] Please visit our website at: www.cytokinetics.com Cytokinetics is an Equal Opportunity Employer Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.

What This Job Offers

• Education Level: No Education Listed
• Number of Employees: 101-250 employees